Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA vaccines.

J Encke1, J zu Putlitz, J R Wands

  • 1Molecular Hepatology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Mass., USA.

Intervirology
|October 12, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Conversion of sound into auditory nerve action potentials].

HNO·2016
Same author

Functional consequences of WNT3/Frizzled7-mediated signaling in non-transformed hepatic cells.

Oncogenesis·2013
Same author

Activation of natural killer cells by hepatitis C virus particles in vitro.

Clinical and experimental immunology·2011
Same author

Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells.

Journal of viral hepatitis·2009
Same author

An early increase in gamma glutamyltranspeptidase and low aspartate aminotransferase peak values are associated with superior outcomes after orthotopic liver transplantation.

Transplantation proceedings·2009
Same author

Fatal varicella in an immunocompromised adult associated with a European genotype E2 variant of varicella zoster virus.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2008
Same journal

Formulated curcumin exerts potent anti-influenza activity by inhibition of Akt activation and viral genome replication.

Intervirology·2026
Same journal

Isolation of a Variant of the Felid Herpesvirus 1-Live Attenuated Vaccine Strain F2 from Unvaccinated Cats.

Intervirology·2026
Same journal

Antiviral activity of the chemokine CXCL10 against West Nile virus.

Intervirology·2025
Same journal

Serological Evidence of Bluetongue Virus Serotypes Circulating in Pakistan.

Intervirology·2025
Same journal

Expression of Concern.

Intervirology·2025
Same journal

Genetic and Antigenic Variability in VP4 and VP7 of Group A Human Rotavirus in Yunnan, China, from 2015 to 2020.

Intervirology·2025
See all related articles

Genetic immunization using DNA encoding hepatitis B (HBV) and hepatitis C (HCV) proteins in mice successfully generated cellular immune responses. This approach shows promise for developing new vaccines against these chronic viral infections.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Chronic hepatitis B (HBV) and hepatitis C (HCV) infections are significant global health issues.
  • These viral infections can lead to severe liver conditions, including liver disease and hepatocellular carcinoma.
  • Current treatment and prevention strategies for HBV and HCV require further development.

Purpose of the Study:

  • To investigate the potential of DNA-based immunization for inducing immune responses against HBV and HCV.
  • To evaluate the cellular immune response generated by genetic immunization with viral proteins.
  • To explore the feasibility of DNA-based vaccines for therapeutic and prophylactic use against HBV and HCV.

Main Methods:

  • Experimental mice were immunized using DNA encoding structural and nonstructural proteins of HBV and HCV.

Related Experiment Videos

  • The study focused on assessing the cellular immune response, specifically CD4+ and CD8+ T-cell responses.
  • Analysis involved evaluating the breadth and effectiveness of the immune response generated by genetic immunization.

    • Main Results:

    • Genetic immunization with DNA encoding HBV and HCV proteins elicited a broad CD4+ and CD8+ cellular immune response in experimental mice.
    • The induced immune response suggests a potential mechanism for viral clearance from the host.
    • DNA-based immunization proved effective in generating a significant cellular immune response against the targeted viruses.

    Conclusions:

    • DNA-based immunization is a promising strategy for developing vaccines against HBV and HCV.
    • The induction of robust cellular immunity is crucial for controlling and potentially clearing HBV and HCV infections.
    • This approach holds potential for both therapeutic and prophylactic vaccine development against chronic hepatitis viruses.